Vaccination with porcine reproductive and respiratory syndrome killed virus vaccine and immunostimulatory oligodeoxynucleotides induces specific immunity in piglets.
A large number of studies demonstrated the immunostimulatory effects of CpG oligonucleotides (ODN), particularly in mice. In present study, the objective was to investigate the immunoadjuvant effects of CpG ODN to porcine reproductive and respiratory syndrome (PRRS) killed virus vaccine (PRRSV) and its protective effects against PRRS virus in piglets. The PRRSV-specific antibodies titres and serum IgG1/IgG2 titres, the proliferation of lymphocytes, PRRSV-specific IFN-gamma, the expression of major histocompatibility complex class II (MHCII) of peripheral blood mononuclear cells (PBMCs) and post-challenge clinical protection were examined to identify the immune responses of the piglets. The results were found that the above-mentioned immune responses of the piglets inoculated with CpG ODN plus PRRSV were significantly stronger than those indued by PRRSV or PBS control groups. All these data suggested that CpG ODN could be employed as effective immunoadjuvant to raise the humoral and cellular responses of the piglets to PRRSV.
Linghua
Zhang
Z
Microbiological Staff Room, College of Life Sciences, South China Agricultural University, Wushan Road, Tianhe district, Guangzhou, GuangDong 510642, China. lhzhang73212000@yahoo.com.cn
Xingshan
Tian
T
Fengzhen
Zhou
Z
D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D000818:Animals; D000914:Antibodies, Viral / Q000097:blood; D000949:Histocompatibility Antigens Class II / Q000096:biosynthesis; D007074:Immunoglobulin G / Q000097:blood; D007371:Interferon-gamma / Q000096:biosynthesis; D009838:Oligodeoxyribonucleotides / Q000008:administration & dosage / Q000276:immunology*; D019318:Porcine Reproductive and Respiratory Syndrome / Q000276:immunology / Q000503:physiopathology / Q000517:prevention & control*; D019316:Porcine respiratory and reproductive syndrome virus / Q000276:immunology*; D016019:Survival Analysis; D034421:Sus scrofa; D013601:T-Lymphocytes / Q000276:immunology; D014765:Viral Vaccines / Q000008:administration & dosage / Q000276:immunology*
D000276:Adjuvants, Immunologic; D000914:Antibodies, Viral; C408982:CPG-oligonucleotide; D000949:Histocompatibility Antigens Class II; D007074:Immunoglobulin G; D009838:Oligodeoxyribonucleotides; D014765:Viral Vaccines; D007371:Interferon-gamma